3-oxoglycyrrhetinic acid has been researched along with bis(4-nitrophenyl)phosphate in 1 studies
*bis(4-nitrophenyl)phosphate: RN given refers to parent cpd [MeSH]
*bis(4-nitrophenyl)phosphate: RN given refers to parent cpd [MeSH]
Studies (3-oxoglycyrrhetinic acid) | Trials (3-oxoglycyrrhetinic acid) | Recent Studies (post-2010) (3-oxoglycyrrhetinic acid) | Studies (bis(4-nitrophenyl)phosphate) | Trials (bis(4-nitrophenyl)phosphate) | Recent Studies (post-2010) (bis(4-nitrophenyl)phosphate) |
---|---|---|---|---|---|
10 | 0 | 6 | 147 | 1 | 42 |
Protein | Taxonomy | 3-oxoglycyrrhetinic acid (IC50) | bis(4-nitrophenyl)phosphate (IC50) |
---|---|---|---|
Cocaine esterase | Homo sapiens (human) | 5.215 | |
Liver carboxylesterase 1 | Homo sapiens (human) | 0.2 | |
Liver carboxylesterase | Sus scrofa (pig) | 1.8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ge, GB; Hao, DC; Hou, J; Jin, Q; Li, YG; Wang, P; Yang, L; Zhou, K; Zou, LW | 1 |
1 other study(ies) available for 3-oxoglycyrrhetinic acid and bis(4-nitrophenyl)phosphate
Article | Year |
---|---|
Design, synthesis, and structure-activity relationship study of glycyrrhetinic acid derivatives as potent and selective inhibitors against human carboxylesterase 2.
Topics: Carboxylesterase; Drug Design; Enzyme Inhibitors; Glycyrrhetinic Acid; Humans; Molecular Docking Simulation; Structure-Activity Relationship | 2016 |